Annual CFF
$126.55 M
+$40.89 M+47.74%
December 31, 2024
Summary
- As of February 24, 2025, ORIC annual cash flow from financing activities is $126.55 million, with the most recent change of +$40.89 million (+47.74%) on December 31, 2024.
- During the last 3 years, ORIC annual CFF has risen by +$77.41 million (+157.55%).
- ORIC annual CFF is now -49.49% below its all-time high of $250.51 million, reached on December 31, 2020.
Performance
ORIC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$575.00 K
+$449.00 K+356.35%
December 31, 2024
Summary
- As of February 24, 2025, ORIC quarterly cash flow from financing activities is $575.00 thousand, with the most recent change of +$449.00 thousand (+356.35%) on December 31, 2024.
- Over the past year, ORIC quarterly CFF has stayed the same.
- ORIC quarterly CFF is now -99.55% below its all-time high of $126.99 million, reached on June 30, 2020.
Performance
ORIC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$126.55 M
+$122.00 K+0.10%
December 31, 2024
Summary
- As of February 24, 2025, ORIC TTM cash flow from financing activities is $126.55 million, with the most recent change of +$122.00 thousand (+0.10%) on December 31, 2024.
- Over the past year, ORIC TTM CFF has stayed the same.
- ORIC TTM CFF is now -49.81% below its all-time high of $252.16 million, reached on March 31, 2021.
Performance
ORIC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ORIC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.7% | 0.0% | 0.0% |
| 3 y3 years | +157.6% | +1754.8% | +15.0% |
| 5 y5 years | +78.7% | +1754.8% | +15.0% |
ORIC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +401.7% | -99.5% | -100.0% | -39.9% | >+9999.0% |
| 5 y | 5-year | -49.5% | +401.7% | -99.5% | +135.3% | -49.8% | >+9999.0% |
| alltime | all time | -49.5% | +401.7% | -99.5% | +135.3% | -49.8% | >+9999.0% |
ORIC Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $126.55 M(+47.7%) | $575.00 K(+356.3%) | $126.55 M(+0.1%) |
| Sep 2024 | - | $126.00 K(-84.6%) | $126.42 M(+0.1%) |
| Jun 2024 | - | $816.00 K(-99.3%) | $126.33 M(-40.0%) |
| Mar 2024 | - | $125.03 M(>+9900.0%) | $210.69 M(+146.0%) |
| Dec 2023 | $85.66 M(+239.6%) | $453.00 K(+1361.3%) | $85.66 M(-22.1%) |
| Sep 2023 | - | $31.00 K(-100.0%) | $110.00 M(+0.0%) |
| Jun 2023 | - | $85.17 M(>+9900.0%) | $109.97 M(+336.2%) |
| Mar 2023 | - | $0.00(-100.0%) | $25.21 M(-0.1%) |
| Dec 2022 | $25.23 M(-48.7%) | $24.79 M(>+9900.0%) | $25.23 M(+1926.1%) |
| Sep 2022 | - | $1000.00(-99.8%) | $1.25 M(-97.5%) |
| Jun 2022 | - | $415.00 K(+2493.8%) | $49.83 M(+1.4%) |
| Mar 2022 | - | $16.00 K(-98.0%) | $49.13 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $49.13 M(-80.4%) | $813.00 K(-98.3%) | $49.13 M(-71.7%) |
| Sep 2021 | - | $48.59 M(<-9900.0%) | $173.82 M(+39.2%) |
| Jun 2021 | - | -$281.00 K(-1856.3%) | $124.89 M(-50.5%) |
| Mar 2021 | - | $16.00 K(-100.0%) | $252.16 M(+0.7%) |
| Dec 2020 | $250.51 M(+253.7%) | $125.50 M(<-9900.0%) | $250.51 M(+100.5%) |
| Sep 2020 | - | -$341.00 K(-100.3%) | $124.96 M(-4.6%) |
| Jun 2020 | - | $126.99 M(-7904.9%) | $131.00 M(+142.9%) |
| Mar 2020 | - | -$1.63 M(+2567.2%) | $53.93 M(-23.8%) |
| Dec 2019 | $70.82 M(+86.3%) | -$61.00 K(-101.1%) | $70.82 M(-0.1%) |
| Sep 2019 | - | $5.70 M(-88.6%) | $70.89 M(+8.7%) |
| Jun 2019 | - | $49.92 M(+227.1%) | $65.19 M(+327.1%) |
| Mar 2019 | - | $15.26 M | $15.26 M |
| Dec 2018 | $38.01 M | - | - |
FAQ
- What is ORIC Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals annual CFF year-on-year change?
- What is ORIC Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals quarterly CFF year-on-year change?
- What is ORIC Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals TTM CFF year-on-year change?
What is ORIC Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of ORIC is $126.55 M
What is the all time high annual CFF for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high annual cash flow from financing activities is $250.51 M
What is ORIC Pharmaceuticals annual CFF year-on-year change?
Over the past year, ORIC annual cash flow from financing activities has changed by +$40.89 M (+47.74%)
What is ORIC Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of ORIC is $575.00 K
What is the all time high quarterly CFF for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high quarterly cash flow from financing activities is $126.99 M
What is ORIC Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, ORIC quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is ORIC Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of ORIC is $126.55 M
What is the all time high TTM CFF for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high TTM cash flow from financing activities is $252.16 M
What is ORIC Pharmaceuticals TTM CFF year-on-year change?
Over the past year, ORIC TTM cash flow from financing activities has changed by $0.00 (0.00%)